The common standard of treatment for tendonitis usually involves cortisone shots, medication, physical therapy and sometimes surgery. Platelet rich plasma, utilized for years to heal bone injuries, is now being examined across the United States as a possible treatment for soft tissue injuries such as tendonitis. Dr. Alan Mishra, an adjunct clinical professor of orthopedic surgery at Stanford University in Palo Alto, California, and the director of Total Tendon, joins host Dr. Shira Johnson to discuss his research on platelet rich plasma in this rapidly evolving field.
Evaluating Platelet Rich Plasma Treatment for Tendonitis

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The common standard of treatment for tendonitis usually involves cortisone shots, medication, physical therapy and sometimes surgery. Platelet rich plasma, utilized for years to heal bone injuries, is now being examined across the United States as a possible treatment for soft tissue injuries such as tendonitis. Dr. Alan Mishra, an adjunct clinical professor of orthopedic surgery at Stanford University in Palo Alto, California, and the director of Total Tendon, joins host Dr. Shira Johnson to discuss his research on platelet rich plasma in this rapidly evolving field.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
Engaging Patients and Caregivers About Digital Therapeutics
FCS and SHTG: Are We Meeting the Need?
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Collaborative Insights to Solve the Puzzle of Bladder Cancer
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?